Literature DB >> 20670202

TRPM2 channel properties, functions and therapeutic potentials.

Lin-Hua Jiang1, Wei Yang, Jie Zou, David J Beech.   

Abstract

IMPORTANCE OF THE FIELD: Oxidative stress, through production of reactive oxygen species, triggers disturbance in intracellular calcium [Ca(2+)](i) homeostasis, which has been identified as an important causative factor in the pathogenesis of numerous inflammatory, cardiovascular and neurodegenerative diseases. AREAS COVERED IN THIS REVIEW: Transient receptor potential melastatin 2 (TRPM2) protein forms a Ca(2+)-permeable cationic channel that is activated in response to oxidative stress and therefore acts as a cellular redox sensor. Research over the years has substantially advanced the knowledge of expression and functional properties of the TRPM2 channel, and particularly has accumulated compelling evidence for an important role for TRPM2 channel-mediated extracellular Ca(2+) influx in several physiological and pathophysiological functions exemplified by insulin release from pancreatic beta-cells, production of pro-inflammatory cytokines from immune cells, increased endothelial permeability, microglia activation and cell death. These findings suggest therapeutic potential of the TRPM2 channel as a drug target for combating oxidative-stress-related diseases. WHAT THE READER WILL GAIN: The current state of knowledge with respect to the TRPM2 channel properties and the roles in oxidant stress signalling and functions. TAKE HOME MESSAGE: TRPM2 may be a novel therapeutic target for oxidative stress-related diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670202     DOI: 10.1517/14728222.2010.510135

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  39 in total

Review 1.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  Role of TRP channels in the regulation of the endosomal pathway.

Authors:  Ken Abe; Rosa Puertollano
Journal:  Physiology (Bethesda)       Date:  2011-02

3.  Transient Receptor Potential Ion Channel-Dependent Toxicity of Silica Nanoparticles and Poly(amido amine) Dendrimers.

Authors:  Raziye Mohammadpour; Mostafa Yazdimamaghani; Christopher A Reilly; Hamidreza Ghandehari
Journal:  J Pharmacol Exp Ther       Date:  2018-11-15       Impact factor: 4.030

4.  Effects of calcium-binding sites in the S2-S3 loop on human and Nematostella vectensis TRPM2 channel gating processes.

Authors:  Yu-Huan Luo; Xia-Fei Yu; Cheng Ma; Fan Yang; Wei Yang
Journal:  J Zhejiang Univ Sci B       Date:  2019 Dec.       Impact factor: 3.066

Review 5.  Detrimental or beneficial: the role of TRPM2 in ischemia/reperfusion injury.

Authors:  Kai-yu Zhan; Pei-lin Yu; Chun-hui Liu; Jian-hong Luo; Wei Yang
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

6.  Zinc inactivates melastatin transient receptor potential 2 channels via the outer pore.

Authors:  Wei Yang; Paul T Manna; Jie Zou; Jianhong Luo; David J Beech; Asipu Sivaprasadarao; Lin-Hua Jiang
Journal:  J Biol Chem       Date:  2011-05-20       Impact factor: 5.157

Review 7.  Nociceptive Roles of TRPM2 Ion Channel in Pathologic Pain.

Authors:  Yongwoo Jang; Pyung Sun Cho; Young Duk Yang; Sun Wook Hwang
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 8.  TRPM2: a multifunctional ion channel for calcium signalling.

Authors:  Adriana Sumoza-Toledo; Reinhold Penner
Journal:  J Physiol       Date:  2010-12-06       Impact factor: 5.182

9.  A residue in the TRPM2 channel outer pore is crucial in determining species-dependent sensitivity to extracellular acidic pH.

Authors:  Jie Zou; Wei Yang; David J Beech; Lin-Hua Jiang
Journal:  Pflugers Arch       Date:  2011-04-20       Impact factor: 3.657

10.  Sexually dimorphic response of TRPM2 inhibition following cardiac arrest-induced global cerebral ischemia in mice.

Authors:  S Nakayama; R Vest; R J Traystman; P S Herson
Journal:  J Mol Neurosci       Date:  2013-03-27       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.